| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/27/2005 | CN1646098A Pharmaceutical formulation comprising melatonin |
| 07/27/2005 | CN1646097A Chemosensitizing with liposomes containing oligonucleotides |
| 07/27/2005 | CN1646095A Inhalation kit comprisung inhalable powder of tiotropium |
| 07/27/2005 | CN1646094A A stable pharmaceutical formulation comprising torsemide modification II |
| 07/27/2005 | CN1646093A Method and composition for treatment of inflammation and AIDS-associated neurological disorders |
| 07/27/2005 | CN1646078A Composition for cell proliferation |
| 07/27/2005 | CN1646032A Compositions comprising short and long chain fatty acids and methods of their use for the management of body weight |
| 07/27/2005 | CN1644705A Metabolic compound of HLY2 and its preparation |
| 07/27/2005 | CN1644704A Preparation of highly polyunsaturated fatty acid-containing phosphatidylserine and phosphatidic acid |
| 07/27/2005 | CN1644208A China fir extracts with lycopodine A and B composition and their preparing method |
| 07/27/2005 | CN1644203A Oral preparation of red common stone crop polysaccharide and its making method |
| 07/27/2005 | CN1644202A Cucurbitacin liquid composition and preparation thereof |
| 07/27/2005 | CN1644201A Application of folic acid-containing pharmaceutical compositions |
| 07/27/2005 | CN1644200A Ganciclovir as ophthalmic medicine and its preparation |
| 07/27/2005 | CN1644199A Use of ampeloptin in preparation of antivirus medicines |
| 07/27/2005 | CN1644198A Non-dropped medicine releaser in vagina and its preparation and use |
| 07/27/2005 | CN1644078A Preparation for lipoid frame particle |
| 07/27/2005 | CN1644075A Production of powdery lipoid |
| 07/27/2005 | CN1212398C Novel IFN receptor 1 binding proteins, DNA encoding them, and method of modulating cellular response to interferons |
| 07/27/2005 | CN1212330C Medicinal complex dibaicalin zinc and its preparation method |
| 07/27/2005 | CN1212329C Matching substance with flavone contained in erigeron breviscapus as ligand and its usage |
| 07/27/2005 | CN1212324C Method for preparing crystalline cefathiamidine and its usage |
| 07/27/2005 | CN1212321C Industrial synthetising strontium salt and method of its hydrate |
| 07/27/2005 | CN1212317C Novel ester or amide derivatives |
| 07/27/2005 | CN1212315C Coffee acyl naphthalene sulfonamides compound and method for preparing the same and anti-HIV conformity enzyme action |
| 07/27/2005 | CN1212311C Acrylonitrile compounds, process for their prodn, and pesticides containing them |
| 07/27/2005 | CN1212310C Propanol amine kind ether compound synthesized using paeonol as mother body and its derivative |
| 07/27/2005 | CN1212309C Propanol amine kind ether compound synthesized using paeonol as mother body and its derivative |
| 07/27/2005 | CN1212303C Method for synthesizing conjugated linoleic acid using mixed solvent |
| 07/27/2005 | CN1212299C Purification of xanthophylls from marigold extracts containing high levels of chlorophylls |
| 07/27/2005 | CN1212166C Safety shield system for prefilled syringes |
| 07/27/2005 | CN1212154C Gel delivery vehicles for anticellular proliferative agent |
| 07/27/2005 | CN1212153C Immunologic adjuvant origniated from plants, and its preparing method and use |
| 07/27/2005 | CN1212127C Medicated sanitary article for treating gynopathy and its preparation |
| 07/27/2005 | CN1212126C Nano hydroxy apatite calcium supplementing agent |
| 07/27/2005 | CN1212125C Strontium-calcium composite tonic series and its preparation |
| 07/27/2005 | CN1212124C Preparation for injecting temperature sensitive gelatin embolism material |
| 07/27/2005 | CN1212123C Fat-binding polymers |
| 07/27/2005 | CN1212122C Notiginseng total saponin liposome and its preparation |
| 07/27/2005 | CN1212121C Product of ginsenoside for curing hepatitis |
| 07/27/2005 | CN1212120C Ointment prescription for treating trauma |
| 07/27/2005 | CN1212119C Organic compounds |
| 07/27/2005 | CN1212118C Preparation method of powder-injections of cyclonorfloxacin and its salts and their preparation products |
| 07/27/2005 | CN1212117C Medicine composition for treating diabetes mellitus |
| 07/27/2005 | CN1212116C Sophorcarpidine alkaloid and decongestant compound medicine and its preparation |
| 07/27/2005 | CN1212115C Water soluble vitamin product coated with micro capsule and its producing method |
| 07/27/2005 | CN1212114C Oral breviscapine slow release prepn |
| 07/27/2005 | CN1212113C Total emodin anthraquinone granule and its prepn. and prepn. of dispersive Sanhuang tablet |
| 07/27/2005 | CN1212080C Composition containing fat-soluble vitamins |
| 07/26/2005 | US6921835 Carbocyclic carboxy amines such as 1-aminomethyl-3,4-dimethyl-cyclopentyl acetic acid or prodrugs used as antiepileptics, antidepressants, anxiolytics, analgesics, antiinflammatory agents and for prophylaxis of neurodegenerative disorders |
| 07/26/2005 | US6921826 Thioether substituted imidazoquinolines |
| 07/26/2005 | US6921825 Pyrazolo-triazolo- pyrimidine, triazolo-triazolo-pyrimidine and imidazolo-triazolo-pyrimidine derivatives useful for the treatment of hypertension, inflammation, mast cell degranulation, cardiac hypoxia, and ischemia |
| 07/26/2005 | US6921824 Ruthenium dimeric complexes suitable as antimetastatic and antineoplastic agents |
| 07/26/2005 | US6921823 1,2,3,4,5,6-Hexahydroazepino[4,5-b]indoles containing arylsulfones at the 9-position |
| 07/26/2005 | US6921821 Antagonists of melanin concentrating hormone receptor |
| 07/26/2005 | US6921810 Bifunctional antibiotics |
| 07/26/2005 | US6921777 E.g., ethyl 3-methyl-5-(,5,8,8-tetra-methyl-5,6,7,8-tetra-hydronaphthalen-2 -ylselenyl)pent-2-en-4-ynoate; dermatological, rheumatic, respiratory, cardiovascular and ophthalmological uses as well as cosmetic uses |
| 07/26/2005 | US6921776 Non-steroidal sulphamate compound for use as oestrone sulphatase inhibitor |
| 07/26/2005 | US6921775 Glutamate receptor antagonist |
| 07/26/2005 | US6921774 Administering compounds such as N-(3-(5-Cyano-1-(4-fluoro-phenyl)-1,3-dihydroisobenzofuran-1-yl)-1 -propyl)glycine ethyl ester, for prophylaxis of psychological disorders |
| 07/26/2005 | US6921773 Use of α-1AR subtype-selective drugs in patients with acute myocardial infarction |
| 07/26/2005 | US6921772 Methods and compositions for the treatment of chronic lymphocytic leukemia |
| 07/26/2005 | US6921771 Administering a fused aminoquinoline derivative such as (5R)-5-(methylamino)-5,6-dihydro-4H-imidazo(4,5,1-ij) quinoline-2(1H)-thione or pharmaceutically acceptable salts |
| 07/26/2005 | US6921766 Blood vessel lipid deposition-preventive agent comprising chymase-inhibitor |
| 07/26/2005 | US6921765 1-Azabicyclo[2.2.2]octan-3-one derivatives and maleimide derivatives and their use for treating cancer tumors |
| 07/26/2005 | US6921763 Protein kinase inhibitors |
| 07/26/2005 | US6921762 Substituted indolizine-like compounds and methods of use |
| 07/26/2005 | US6921761 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 07/26/2005 | US6921760 Psychotherapeutic agents. |
| 07/26/2005 | US6921759 For therapy, prophylaxis or delaying the onset of AIDS and infection by HIV |
| 07/26/2005 | US6921758 Amino acid derivatives |
| 07/26/2005 | US6921757 Conversion of carboxylic acid substituent in a gonane ring, into the methyl ester, or hydrochlorination of a 9-11-epoxy-9-H-cyclopenta(a)phenanthrene compounds |
| 07/26/2005 | US6921754 Compositions containing folic acid and reduced folate |
| 07/26/2005 | US6921752 Use of LTB4 antagonists in veterinary medicine |
| 07/26/2005 | US6921650 Recombinant methods and materials for producing epothilone and epothilone derivatives |
| 07/26/2005 | US6921541 Formulations and methods for providing prolonged local anesthesia |
| 07/26/2005 | US6921539 For therapy of bacterial, fungal, and protozoan infections |
| 07/26/2005 | US6921529 Increasing the drug delivery by including hydrogel for supporting on a extended period of time to diffuse the antimycotic agent through the nail; sustained release |
| 07/26/2005 | US6921528 Highly efficient delivery of a large therapeutic mass aerosol |
| 07/26/2005 | US6921527 Dispersable dry powder; controlling moisture concentration, particle size; in situ drug delivery |
| 07/26/2005 | CA2470200C Pharmaceutical composition |
| 07/26/2005 | CA2363902C Process and system for controlled-release drug delivery |
| 07/26/2005 | CA2324848C Method of making camptothecin and camptothecin analogs |
| 07/26/2005 | CA2322644C Pharmaceutical composition of topiramate |
| 07/26/2005 | CA2315481C Selective inhibition of aggrecanase in osteoarthritis treatment |
| 07/26/2005 | CA2294562C Hepatitis c inhibitor peptide analogues |
| 07/26/2005 | CA2285203C Compositions containing capsaicin or capsaicin analogues and a local anesthetic |
| 07/26/2005 | CA2256609C 5-aroylpyrrol-2-ylmethylarene derivatives as inhibitors of prostaglandin g/h synthase |
| 07/26/2005 | CA2253948C Carboline derivatives |
| 07/26/2005 | CA2234642C 3,4-diaryl-2-hydroxy-2,5-dihydrofurans as prodrugs to cox-2 inhibitors |
| 07/26/2005 | CA2233108C Complex of y-cyclodextrin and retinol or retinol derivatives, processes for their preparation and their use |
| 07/26/2005 | CA2193388C Aryl and heteroaryl alkoxynaphthalene derivatives |
| 07/26/2005 | CA2175498C Phenylindole compounds |
| 07/26/2005 | CA2171740C 0rally active derivatives of 1,3,5(10)-estratriene |
| 07/26/2005 | CA2153326C Taxane formulations comprising phospholipids |
| 07/26/2005 | CA2152902C Selective ligands of receptors 5-ht1d-5ht1b derived from indole-piperazine useful as medicaments |
| 07/26/2005 | CA2152630C Enantiomers of carbazole derivatives as 5-ht1-like agonists |
| 07/26/2005 | CA2149766C Rectal flunisolide compositions for treating inflammatory intestinal disorders |
| 07/26/2005 | CA2149007C Cyclohexane derivatives, process for their preparation, and the use of the compounds for the treatment of diseases |
| 07/26/2005 | CA2137623C Phenyl-substituted 1,4-dihydropyridines |